Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-25-000342
Filing Date
2025-05-14
Accepted
2025-05-14 17:03:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5844
  Complete submission text file 0000898432-25-000342.txt   7319
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90473 | Film No.: 25946925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TATTVA FIDUCIARY COMPANY 100 WEST LIBERTY STREET, 10TH FLOOR RENO NV 89501
Business Address
Mahesh Akram (Filed by) CIK: 0002006625 (see all company filings)

Type: SCHEDULE 13G/A